Zimmer Biomet Holdings, Inc <ZBH.N>: UBS Assumes Coverage With Buy vs Sell Rating; Price Target $115 vs $89
ZBH•Related News
BetMGM sees FY 2026 net revenue, adjusted EBITDA near low end of guidance ranges
MGM•
Everspin CEO, CFO to present at Oppenheimer Technology, Internet & Communications Conference
MRAM•
US Stocks-Nasdaq futures slide as AI worries mount ahead of pivotal earnings
QQQ•
Redwood Trust Q2 net loss narrows sequentially, mortgage banking production doubles y/y
RWT•
Vestis sets fiscal Q3 earnings release, conference call and webcast
VSTS•